All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The emerging role of MRD in the treatment of chronic lymphocytic leukemia
In this review, we summarize the role of MRD in the treatment of CLL, including methods of detection, clinical data on MRD significance, MRD-guided treatment strategies, and...
EHA2023 abstracts: What’s hot in lymphoma and CLL?
To help navigate the exciting content being presented at EHA2023, the Lymphoma Hub Steering Committee have provided their recommendations for the top abstracts to look out for in lymphoma and CLL.
Your opinion matters
Are you a healthcare professional? What is your specialty?
Please select or type your specialty
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.